A cathinone is a stimulant compound originally found in the leaves of the khat plant, a shrub grown across East Africa and the Arabian Peninsula. Chemically, it’s closely related to amphetamine, with one key difference: cathinones have an extra oxygen atom attached to their structure (a ketone group). That small molecular tweak creates an entire family of drugs, both natural and synthetic, that boost energy and alertness by flooding the brain with feel-good chemicals. The synthetic versions, sometimes sold as “bath salts,” have become a significant public health concern worldwide.
The Khat Plant: Where Cathinone Comes From
Natural cathinone is one of the active ingredients in khat (Catha edulis), a flowering plant cultivated in Yemen, Ethiopia, Kenya, and neighboring countries. People in these regions have chewed khat leaves for centuries as a social and cultural practice. Chewing releases cathinone slowly, producing mild stimulation, increased talkativeness, and a sense of well-being. The practice plays a role in social gatherings, religious observance, and ceremonies like weddings. Some Muslim communities in Yemen believe it helps facilitate prayer, though khat chewing crosses religious lines and is common among Christians and other groups as well.
Fresh khat leaves contain the most cathinone. Once picked, the compound begins breaking down within about 48 hours into a weaker stimulant called cathine. This is why khat users prefer freshly harvested leaves and why the plant has historically stayed regional: it doesn’t ship well over long distances.
How Cathinones Affect the Brain
Cathinones work by disrupting the brain’s system for recycling three chemical messengers: dopamine (involved in pleasure and reward), norepinephrine (which drives alertness and the “fight or flight” response), and serotonin (which regulates mood and body temperature). Normally, after these chemicals do their job in the gap between nerve cells, specialized transporters pull them back inside the neuron for reuse.
Cathinones interfere with this recycling process in two possible ways, depending on the specific compound. Some act as “releasers,” essentially hijacking the transporters and forcing them to push neurotransmitters out of the neuron in the wrong direction. Others act as “blockers,” parking themselves on the transporter and preventing it from pulling neurotransmitters back in. Both approaches have the same net result: dopamine, norepinephrine, and serotonin build up in the spaces between neurons, amplifying their signals far beyond normal levels. This is what produces the rush of energy, euphoria, and heightened focus users report.
The balance between these three chemicals matters. Cathinones that hit dopamine hardest tend to be more addictive and produce more intense euphoria. Those that strongly affect serotonin are more likely to cause hallucinations, dangerous overheating, and a potentially fatal condition called serotonin syndrome, where the body’s temperature regulation spirals out of control.
Natural vs. Synthetic Cathinones
Natural cathinone from khat is a relatively mild stimulant, roughly comparable in strength to a strong cup of coffee when chewed in traditional amounts. Synthetic cathinones are a different story. Chemists can modify the basic cathinone structure in dozens of ways, creating compounds that are far more potent and unpredictable than the natural version.
The most well-known synthetic cathinones include mephedrone, MDPV (sometimes called “bath salts”), and methylone. These gained popularity in the late 2000s and early 2010s because they were legal in many countries and easy to buy online, often labeled as “plant food” or “bath salts” to skirt drug regulations. One prescription medication, bupropion (used for depression and smoking cessation), is also technically a cathinone derivative, though it was specifically designed to act more gently on dopamine and norepinephrine without producing a recreational high.
The synthetic cathinone market keeps shifting. After governments ban one compound, manufacturers tweak the molecule slightly to create a new, technically legal version. In Europe, nearly 30 new cathinones appeared each year during the peak of the “legal highs” era in 2014 and 2015. By 2024, that number had dropped to seven new variants, though the cat-and-mouse game continues. When the Netherlands recently banned 3-MMC and 3-CMC (two popular synthetic cathinones), a compound called 2-MMC quickly emerged as a replacement. Drug checking services in 10 EU countries found that half of samples sold as 3-MMC in early 2024 actually contained 2-MMC instead.
Short-Term Effects and Risks
At lower doses, cathinones produce effects similar to other stimulants: increased energy, reduced appetite, heightened sociability, and euphoria. Users often report feeling more talkative and confident. These effects typically last a few hours, though some synthetic cathinones (particularly MDPV and its relatives) can produce effects lasting much longer.
The risks escalate quickly with higher doses or repeated use. Physical effects include rapid heart rate, high blood pressure, chest pain, and dangerous spikes in body temperature. The cardiovascular risks range from mild racing heartbeat to heart attacks and fatal arrhythmias. Overheating (hyperthermia) is one of the most dangerous acute effects, because it can trigger a cascade of organ damage that becomes difficult to reverse.
Psychological effects can be equally severe. Mild agitation and anxiety at moderate doses can progress to full-blown paranoia, hallucinations, and psychosis at higher doses. A particularly dangerous pattern called excited delirium involves extreme agitation, confusion, superhuman-seeming strength, and loss of pain sensitivity. This state carries a high risk of death from cardiac arrest or organ failure. Seizures and coma have also been documented.
Detection in Drug Tests
Standard drug screens don’t reliably catch synthetic cathinones. Most workplace and hospital urine tests are designed to detect amphetamines, opioids, and other traditional drugs, and cathinones often slip through undetected. Specialized testing using advanced laboratory methods is needed to identify specific cathinones.
One advantage for testing, compared to some other synthetic drugs, is that the parent cathinone compounds show up intact in urine rather than breaking down into hard-to-identify metabolites. For compounds like MDPV, the elimination half-life in urine is roughly 12 hours, meaning the drug clears the body relatively quickly. This creates a narrow detection window, so timing matters if testing is being done after suspected use.
Legal Status in the United States
Natural cathinone is a Schedule I controlled substance under federal law, meaning it’s considered to have high abuse potential and no accepted medical use. The Synthetic Drug Abuse Prevention Act of 2012 placed mephedrone and MDPV in the same category. Since then, the DEA has permanently scheduled methylone and 10 additional synthetic cathinones, with more added through temporary controls, including compounds like N-ethylpentylone in 2018 and six others in 2019.
Even cathinones that aren’t specifically named in the law can be prosecuted under the Controlled Substance Analogue Enforcement Act, which allows any substance substantially similar in chemistry or effect to a Schedule I drug to be treated as one. This is the legal tool designed to keep up with the constantly shifting landscape of new synthetic variants.
Overdose and Emergency Treatment
There is no antidote for cathinone overdose. No established treatment protocol exists specifically for these drugs, so emergency care focuses on managing symptoms as they appear: controlling seizures, bringing down dangerously high body temperature, stabilizing heart rhythm, and sedating patients in severe agitation. The unpredictability of synthetic cathinones makes overdoses particularly challenging, since the exact compound and dose are rarely known, and different cathinones can produce very different toxic effects.
Fatal cases typically involve cardiac arrest, uncontrollable hyperthermia, or multi-organ failure. Mixing cathinones with other substances, especially alcohol or other stimulants, significantly increases the risk of life-threatening complications.